361 related articles for article (PubMed ID: 17099339)
1. Cardiovascular risk and hormone replacement therapy.
Lawlor DA; Smith GD
Curr Opin Obstet Gynecol; 2006 Dec; 18(6):658-65. PubMed ID: 17099339
[TBL] [Abstract][Full Text] [Related]
2. HRT as secondary prevention of cardiovascular disease.
Ylikorkala O
Maturitas; 2004 Apr; 47(4):315-8. PubMed ID: 15063485
[TBL] [Abstract][Full Text] [Related]
3. Coronary heart disease in menopausal women: implications of primary and secondary prevention trials of hormones.
Rossouw JE
Maturitas; 2005 May; 51(1):51-63. PubMed ID: 15883110
[TBL] [Abstract][Full Text] [Related]
4. Hormone replacement therapy (HRT) and ischaemic heart disease: getting to the heart of the matter.
Chew S; Ng SC
Singapore Med J; 2002 Jan; 43(1):41-4. PubMed ID: 12008777
[TBL] [Abstract][Full Text] [Related]
5. Hormone therapy and selective estrogen receptor modulators for prevention of coronary heart disease in postmenopausal women estrogen replacement from the cardiologist's perspective.
Mobasseri S; Liebson PR; Klein LW
Cardiol Rev; 2004; 12(6):287-98. PubMed ID: 15476565
[TBL] [Abstract][Full Text] [Related]
6. Menopause and stroke and the effects of hormonal therapy.
Lobo RA
Climacteric; 2007 Oct; 10 Suppl 2():27-31. PubMed ID: 17882669
[TBL] [Abstract][Full Text] [Related]
7. Postmenopausal hormone therapy and the risk of cardiovascular disease.
Bittner V
Expert Opin Pharmacother; 2009 Sep; 10(13):2041-53. PubMed ID: 19563274
[TBL] [Abstract][Full Text] [Related]
8. Hormone replacement therapy and cardiovascular disease: increased risks of venous thromboembolism and stroke, and no protection from coronary heart disease.
Lowe GD
J Intern Med; 2004 Nov; 256(5):361-74. PubMed ID: 15485471
[TBL] [Abstract][Full Text] [Related]
9. Postmenopausal hormone therapy and cardiovascular disease: an overview of main findings.
Canonico M; Straczek C; Oger E; Plu-Bureau G; Scarabin PY
Maturitas; 2006 Jul; 54(4):372-9. PubMed ID: 16730142
[TBL] [Abstract][Full Text] [Related]
10. [Hormone replacement in postmenopausal women with coronary heart disease. Results and clinical consequences from recent studies].
Schurz RA; Benzer W
Wien Klin Wochenschr; 1997; 109 Suppl 2():42-5. PubMed ID: 9340923
[TBL] [Abstract][Full Text] [Related]
11. Can menopausal hormone therapy prevent coronary heart disease?
Brinton EA; Hodis HN; Merriam GR; Harman SM; Naftolin F
Trends Endocrinol Metab; 2008 Aug; 19(6):206-12. PubMed ID: 18450469
[TBL] [Abstract][Full Text] [Related]
12. Oral contraceptives, menopause hormone replacement therapy, and risk of stroke.
La Vecchia C
Maturitas; 2004 Apr; 47(4):265-8. PubMed ID: 15063478
[TBL] [Abstract][Full Text] [Related]
13. Oral contraceptives, hormone therapy and cardiovascular risk.
Shapiro S
Climacteric; 2008 Oct; 11(5):355-63. PubMed ID: 18781479
[TBL] [Abstract][Full Text] [Related]
14. Estrogens should not be initiated for the secondary prevention of coronary artery disease: a debate.
Hulley S
Can J Cardiol; 2000 Aug; 16 Suppl E():10E-12E. PubMed ID: 10906618
[TBL] [Abstract][Full Text] [Related]
15. HRT and cardiovascular disease.
Stevenson JC
Best Pract Res Clin Obstet Gynaecol; 2009 Feb; 23(1):109-20. PubMed ID: 19095500
[TBL] [Abstract][Full Text] [Related]
16. Implications of recent clinical trials of postmenopausal hormone therapy for management of cardiovascular disease.
Rossouw JE
Ann N Y Acad Sci; 2006 Nov; 1089():444-53. PubMed ID: 17261787
[TBL] [Abstract][Full Text] [Related]
17. Lessons from hormone replacement therapy trials for primary prevention of cardiovascular disease.
Mohandas B; Mehta JL
Curr Opin Cardiol; 2007 Sep; 22(5):434-42. PubMed ID: 17762545
[TBL] [Abstract][Full Text] [Related]
18. [Hormone replacement therapy and cardiovascular prevention: many statements, some doubts].
Motolese M
Ital Heart J Suppl; 2003 Jul; 4(7):545-58. PubMed ID: 14558283
[TBL] [Abstract][Full Text] [Related]
19. Hormone replacement therapy and cardioprotection: a new dawn? A statement of the Study Group on Cardiovascular Disease in Women of the Italian Society of Cardiology on hormone replacement therapy in postmenopausal women.
Rosano GM; Maffei S; Andreassi MG; Vitale C; Vassalle C; Gambacciani M; Stramba-Badiale M; Mercuro G
J Cardiovasc Med (Hagerstown); 2009 Jan; 10(1):85-92. PubMed ID: 19145119
[TBL] [Abstract][Full Text] [Related]
20. Postmenopausal hormones and coronary artery disease: potential benefits and risks.
Lobo RA
Climacteric; 2007 Oct; 10 Suppl 2():21-6. PubMed ID: 17882668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
